Opus Genetics is building a pipeline of AAV-based retinal gene therapies for patients with rare inherited retinal diseases. We worked with Opus to first create a unique identity that underscores the name and the reference to Opus as a “great work”. Opus was founded by Foundation Fighting Blindness and maintains a strong commitment to patients and families. To this end, we designed the site around photos of real patients along with quotes to express the need and the excitement about the potential for treatments. A robust pipeline, infographics, and scientific illustration work to underscore the scientific approach and progress of their programs into the clinic.
With an initial focus on ocular oncology, Aura is advancing a platform to target solid tumors, using virus-like particles, that can be conjugated with drugs or loaded with nucleic acids to create Virus-Like Drug Conjugates. We worked with Aura to develop a site that presents their story and their commitment to patients with few options for treatment.
Aura became a public company in 2022 and we supported that effort with an investor site design, graphics for the S1, and a video for the NASDAQ tower in Times Square.
Alcyone is creating next-generation precision gene-based therapies for complex neurological conditions. The company integrates innovation in neuroscience, precision dosing platforms, and manufacturing capabilities to deliver transformative therapies to patients. We worked with Alcyone to communicate the breadth of their CNS therapeutic approaches combined with a differentiated and effective delivery system through the development of a variety of corporate materials including a comprehensive company website, coupled with the development of a set of infographics to show each scientific area. We also developed a coordinating stationery system, corporate presentation templates, a scientific poster and presentation set and overall brand standard guide to assist the corporate communications team in overseeing all materials across the three US locations.
Artizan Biosciences creates innovative microbiota-targeted therapies to restore lives disrupted by inflammatory disease by identifying bacteria in the gut that predispose people to disease under specific genetic or environmental conditions.Their proprietary discovery platform that methodically investigates microbial communities and individual bacterial strains from healthy and disease-affected people. Once a strain of interest is identified, Artizan applies its mechanistic research expertise to determine the root causes of pathology and pursue disease-modifying therapeutic strategies.
We worked with Artizan to tell the story of their science and dedication to patients. We created custom images to communicate the company’s scientific focus on the microbiome and walk viewers through the logic of the approach.
Catamaran harnesses the natural cancer-fighting properties of NK cells, the power of synthetic biology and innovative non-viral cell engineering to create novel CAR-NK cell therapies for a highly-differentiated approach for allogeneic cell therapy.
We worked with Catamaran to create a visual brand that captures the feel of the name — the idea of riding above the waves and a feeling of hope for new therapies. The logo represents the double hull of a catamaran as well as their combination of synthetic biology and cell engineering. For the website we combined a simple video of the sun sparkling off the waves with the sale and nautical chart to payoff the “charting a new course” messaging. A set of custom infographics help illustrate the pipeline and create branded visuals for Catamaran’s therapeutic approach.
Paradigm4 provides technology to support decision making and discovery from multidimensional data sets. Their platform and apps help scientists gain insights from varied types of public and private data sets using an intuitive technology setup.
We worked with Paradigm4 to rebrand in a way that describes their value in scientific discovery. First we worked to understand their technology, then organized the content and created visual supports to show how the plaform and apps work together to create a user-friendly environment for discovery. We created the tagline “Multidimensional Insights” and the corresponding graphic — which includes accurate data visualizations — to reinforce the varied types of data that can be cross-referenced on their platform.
Infographics and icons lead the viewer through the site and support key messages.
We worked with Caraway Therapeutics to rename and rebrand the company from Rheostat. Caraway is pursuing novel approaches to treat debilitating neurodegenerative diseases by preserving neurons. It is a leader in the cutting-edge science of activating cellular recycling processes to clear toxic materials and defective cellular components. The name Caraway implies the carrying away and clearing of defective cellular material. The tagline “Clearing Away Neurodegenerative Disease” further underscores the approach. The logo is made of caraway seeds (used to clear breath and aid digestion) and is the basis for a set of custom icons to describe the science and the approach. The website is designed to grow as Caraway advances into the clinic, adds to the team, and develops new programs. Photography of the team and labs personalizes the site and ties the environment to the overall brand.
Acnos Pharma provides global clinical trial supply and general pharmaceutical sales in the EU. The company’s expert team and strategic location ensures that medicines are delivered in a streamlined and efficient manner.
We partnered with Acnos to rebrand the company in a way that focuses on service, expertise, and results. The new logo takes the Acnos “A” and turns it into a dynamic arrow pointing forward with colors that converge to a single point — reflecting all of the moving parts that coordinate within the company to deliver services. This idea then evolved into a set of visuals that use the arrow to show the primary process in the center (medicines deliver to patients) surrounded by all of the services (warehousing, consulting, bar codes, etc.) that contribute to the process. Coordinating infographics and icons provide additional items in the toolkit to highlight services and value.
Collegium Pharmaceutical is committed to being the leader in responsible pain management. For nearly two decades, Collegium has been focused on developing and commercializing new medicines for pain management that reflect their core values and commitment to people suffering from pain, healthcare providers, and communities.
We worked with Collegium to rebrand the company beginning with a new logo that communicates the “collegial” in Collegium. The logo tells the story of multiple parts working together to move pain management forward while bringing the “C” into the center. The logo and colors, combined with custom photography of Collegium’s people and environment build a site that tells the story of their mission, core values, and teamwork.
Talaris is developing a single-dose cell therapy that seeks to free organ transplant recipients of the burdens and toxicities of lifelong immunosuppression, without rejecting their transplanted organ. We began our engagement wih the name — Talaris is adapted from “talaria,” the winged sandals worn by Greek messenger god Hermes, which gave him protection. In a similar way, the facilitating cells central to the platform protect and deliver other immune cells to safety within the recipient patient. The logo is representative of the facilitating cells in combination with the patient and donor cells. Moving forward with the brand, we wanted to represent a wide variety of patients and underscore their experience with the tagline “Live your life. Beyond the transplant.” Custom infographics explain the process and communicate the strong clinical results already established for the therapy as the company moves forward into a phase 3 trial.